Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Inventory (2024 - 2025)

Historic Inventory for ARS Pharmaceuticals (SPRY) over the last 2 years, with Q3 2025 value amounting to $7.8 million.

  • ARS Pharmaceuticals' Inventory rose 98839.16% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 98839.16%. This contributed to the annual value of $5.2 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that ARS Pharmaceuticals reported Inventory of $7.8 million as of Q3 2025, which was up 98839.16% from $8.7 million recorded in Q2 2025.
  • ARS Pharmaceuticals' 5-year Inventory high stood at $8.7 million for Q2 2025, and its period low was $715000.0 during Q3 2024.